**Weekly News Sentiment:** Negative

The current week's news sentiment for Divi's Labs is predominantly negative, with 7 out of 10 news articles having a negative tone. The notable events that contributed to this sentiment are:

* Divi's Labs shares fell nearly 3% after a US court ruled in favor of Novartis, allowing generic competition for its best-selling heart drug.
* The company's stock slipped due to US supply worries.
* Divi's Labs shares fell 6% in trade, worrying investors.
* Pharma CDMO stocks, including Divi's Lab, fell after the US softened its stance on the Biosecure Act.

The only positive news article was about NCC and Divi's Labs being top picks by Ajit Mishra of Religare Broking. However, this was not enough to offset the overall negative sentiment.

The historical similar news and price impact analysis also suggests that the stock has fallen in the past due to similar news events, which adds to the negative sentiment.

Overall, the news tone is negative for Divi's Labs, indicating potential downward pressure on the stock.